These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 21295029)
1. In vitro antimalarial activity of ICL670: a further proof of the correlation between inhibition of β-hematin formation and of peroxidative degradation of hemin. Sonnet P; Mullié C Exp Parasitol; 2011 May; 128(1):26-31. PubMed ID: 21295029 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of ursolic acid derivatives on hydrogen peroxide- and glutathione-mediated degradation of hemin: a possible additional mechanism of action for antimalarial activity. Mullié C; Jonet A; Dassonville-Klimpt A; Gosmann G; Sonnet P Exp Parasitol; 2010 Jul; 125(3):202-7. PubMed ID: 20109452 [TBL] [Abstract][Full Text] [Related]
3. [Comparative observation on inhibition of hemozoin formation and their in vitro and in vivo anti-schistosome activity displayed by 7 antimalarial drugs]. Xue J; Jiang B; Liu CS; Sun J; Xiao SH Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Jun; 31(3):161-9. PubMed ID: 24812850 [TBL] [Abstract][Full Text] [Related]
4. Targeting of hematin by the antimalarial pyronaridine. Auparakkitanon S; Chapoomram S; Kuaha K; Chirachariyavej T; Wilairat P Antimicrob Agents Chemother; 2006 Jun; 50(6):2197-200. PubMed ID: 16723583 [TBL] [Abstract][Full Text] [Related]
5. Objectives and mechanism of iron chelation therapy. Hershko C; Link G; Konijn AM; Cabantchik ZI Ann N Y Acad Sci; 2005; 1054():124-35. PubMed ID: 16339658 [TBL] [Abstract][Full Text] [Related]
6. Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG. Gaboriau F; Leray AM; Ropert M; Gouffier L; Cannie I; Troadec MB; Loréal O; Brissot P; Lescoat G Biometals; 2010 Apr; 23(2):231-45. PubMed ID: 19997770 [TBL] [Abstract][Full Text] [Related]
7. Deferoxamine: stimulation of hematin polymerization and antagonism of its inhibition by chloroquine. Vippagunta SR; Dorn A; Bubendorf A; Ridley RG; Vennerstrom JL Biochem Pharmacol; 1999 Sep; 58(5):817-24. PubMed ID: 10449192 [TBL] [Abstract][Full Text] [Related]
8. Antimalarial acridines: synthesis, in vitro activity against P. falciparum and interaction with hematin. Guetzoyan L; Yu XM; Ramiandrasoa F; Pethe S; Rogier C; Pradines B; Cresteil T; Perrée-Fauvet M; Mahy JP Bioorg Med Chem; 2009 Dec; 17(23):8032-9. PubMed ID: 19879150 [TBL] [Abstract][Full Text] [Related]
9. Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs. Parapini S; Basilico N; Pasini E; Egan TJ; Olliaro P; Taramelli D; Monti D Exp Parasitol; 2000 Dec; 96(4):249-56. PubMed ID: 11162378 [TBL] [Abstract][Full Text] [Related]
10. Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum. Pattanapanyasat K; Kotipun K; Yongvanitchit K; Hider RC; Kyle DE; Heppner DG; Walsh DS Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):64-9. PubMed ID: 11485097 [TBL] [Abstract][Full Text] [Related]
11. Antiproliferative and apoptotic effects in rat and human hepatoma cell cultures of the orally active iron chelator ICL670 compared to CP20: a possible relationship with polyamine metabolism. Lescoat G; Chantrel-Groussard K; Pasdeloup N; Nick H; Brissot P; Gaboriau F Cell Prolif; 2007 Oct; 40(5):755-67. PubMed ID: 17877614 [TBL] [Abstract][Full Text] [Related]
12. Development of tridentate iron chelators: from desferrithiocin to ICL670. Nick H; Acklin P; Lattmann R; Buehlmayer P; Hauffe S; Schupp J; Alberti D Curr Med Chem; 2003 Jun; 10(12):1065-76. PubMed ID: 12678677 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimalarial evaluation of 1, 3, 5-trisubstituted pyrazolines. Acharya BN; Saraswat D; Tiwari M; Shrivastava AK; Ghorpade R; Bapna S; Kaushik MP Eur J Med Chem; 2010 Feb; 45(2):430-8. PubMed ID: 19926176 [TBL] [Abstract][Full Text] [Related]
14. Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells. Glickstein H; El RB; Shvartsman M; Cabantchik ZI Blood; 2005 Nov; 106(9):3242-50. PubMed ID: 16020512 [TBL] [Abstract][Full Text] [Related]
15. Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity. Biot C; Taramelli D; Forfar-Bares I; Maciejewski LA; Boyce M; Nowogrocki G; Brocard JS; Basilico N; Olliaro P; Egan TJ Mol Pharm; 2005; 2(3):185-93. PubMed ID: 15934779 [TBL] [Abstract][Full Text] [Related]
16. Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers. Kontoghiorghes GJ Hemoglobin; 2006; 30(2):329-47. PubMed ID: 16798657 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of deferasirox, deferiprone, and deferoxamine on the growth and virulence of Vibrio vulnificus. Neupane GP; Kim DM Transfusion; 2009 Aug; 49(8):1762-9. PubMed ID: 19413741 [TBL] [Abstract][Full Text] [Related]
19. Chelation of thallium by combining deferasirox and desferrioxamine in rats. Saljooghi AS; Babaie M; Mendi FD; Zahmati M; Saljooghi ZS Toxicol Ind Health; 2016 Jan; 32(1):83-8. PubMed ID: 24021432 [TBL] [Abstract][Full Text] [Related]
20. Antimalarial effect of iron chelators. Gordeuk VR; Loyevsky M Adv Exp Med Biol; 2002; 509():251-72. PubMed ID: 12572998 [No Abstract] [Full Text] [Related] [Next] [New Search]